Literature DB >> 28827365

Capturing LTA4 hydrolase in action: Insights to the chemistry and dynamics of chemotactic LTB4 synthesis.

Alena Stsiapanava1, Bengt Samuelsson2, Jesper Z Haeggström2.   

Abstract

Human leukotriene (LT) A4 hydrolase/aminopeptidase (LTA4H) is a bifunctional enzyme that converts the highly unstable epoxide intermediate LTA4 into LTB4, a potent leukocyte activating agent, while the aminopeptidase activity cleaves and inactivates the chemotactic tripeptide Pro-Gly-Pro. Here, we describe high-resolution crystal structures of LTA4H complexed with LTA4, providing the structural underpinnings of the enzyme's unique epoxide hydrolase (EH) activity, involving Zn2+, Y383, E271, D375, and two catalytic waters. The structures reveal that a single catalytic water is involved in both catalytic activities of LTA4H, alternating between epoxide ring opening and peptide bond hydrolysis, assisted by E271 and E296, respectively. Moreover, we have found two conformations of LTA4H, uncovering significant domain movements. The resulting structural alterations indicate that LTA4 entrance into the active site is a dynamic process that includes rearrangement of three moving domains to provide fast and efficient alignment and processing of the substrate. Thus, the movement of one dynamic domain widens the active site entrance, while another domain acts like a lid, opening and closing access to the hydrophobic tunnel, which accommodates the aliphatic tale of LTA4 during EH reaction. The enzyme-LTA4 complex structures and dynamic domain movements provide critical insights for development of drugs targeting LTA4H.

Entities:  

Keywords:  LTA4 hydrolase; LTB4; X-ray crystallography; drug design; innate immunity

Mesh:

Substances:

Year:  2017        PMID: 28827365      PMCID: PMC5594697          DOI: 10.1073/pnas.1710850114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

Review 2.  Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

Authors:  Jesper Z Haeggström; Colin D Funk
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  The ID23-1 structural biology beamline at the ESRF.

Authors:  Didier Nurizzo; Trevor Mairs; Matias Guijarro; Vicente Rey; Jens Meyer; Pablo Fajardo; Joel Chavanne; Jean Claude Biasci; Sean McSweeney; Edward Mitchell
Journal:  J Synchrotron Radiat       Date:  2006-04-13       Impact factor: 2.616

Review 4.  Leukotrienes.

Authors:  Marc Peters-Golden; William R Henderson
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

5.  Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.

Authors:  M M Thunnissen; P Nordlund; J Z Haeggström
Journal:  Nat Struct Biol       Date:  2001-02

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

8.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

1.  Substrate-dependent modulation of the leukotriene A4 hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammation.

Authors:  Kyung Hyeon Lee; Nadia Fazal Ali; Soo Hyeon Lee; Zhimin Zhang; Marie Burdick; Zachary J Beaulac; Greg Petruncio; Linxia Li; Jiangdong Xiang; Ezra M Chung; Kenneth W Foreman; Schroeder M Noble; Yun M Shim; Mikell Paige
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 2.  Leukotriene biosynthetic enzymes as therapeutic targets.

Authors:  Jesper Z Haeggström
Journal:  J Clin Invest       Date:  2018-07-02       Impact factor: 14.808

3.  Some Biogenetic Considerations Regarding the Marine Natural Product (-)-Mucosin.

Authors:  Jens M J Nolsøe; Marius Aursnes; Yngve H Stenstrøm; Trond V Hansen
Journal:  Molecules       Date:  2019-11-15       Impact factor: 4.411

4.  Transcellular biosynthesis of leukotriene B4 orchestrates neutrophil swarming to fungi.

Authors:  Alex Hopke; Tian Lin; Allison K Scherer; Ashley E Shay; Kyle D Timmer; Brittany Wilson-Mifsud; Michael K Mansour; Charles N Serhan; Daniel Irimia; Bryan P Hurley
Journal:  iScience       Date:  2022-09-28

5.  Theoretical Characterization of the Step-by-Step Mechanism of Conversion of Leukotriene A4 to Leukotriene B4 Catalysed by the Enzyme Leukotriene A4 Hydrolase.

Authors:  Miquel Canyelles-Niño; Àngels González-Lafont; José M Lluch
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

Review 6.  Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.

Authors:  Carla S S Teixeira; Sérgio F Sousa
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.